Home > Journals > Panminerva Medica > Past Issues > Panminerva Medica 2018 December;60(4) > Panminerva Medica 2018 December;60(4):230-1

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

LETTERS TO THE EDITOR   

Panminerva Medica 2018 December;60(4):230-1

DOI: 10.23736/S0031-0808.18.03459-6

Copyright © 2018 EDIZIONI MINERVA MEDICA

language: English

Targeting microRNAs using nanotechnology in pulmonary diseases

Kamal DUA 1, 2, 3 , Dinesh K. CHELLAPPAN 4, Gautam SINGHVI 5, Terezinha de JESUS ANDREOLI PINTO 6, Gaurav GUPTA 7, Philip M. HANSBRO 1, 2, 3

1 Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, Australia; 2 School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, Australia; 3 The Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Newcastle, Australia; 4 Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Malaysia; 5 Department of Pharmacy, Birla Institute of Technology and Science (BITS), Pilani, India; 6 Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil; 7 School of Pharmaceutical Sciences, Jaipur National University, Jagatpura, India



top of page